Φορτώνει......
Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension
BACKGROUND: Previous clinical trials with birch pollen subcutaneous immunotherapy have been conducted over a 1‐ to 2‐year treatment period and involved mostly a single geographic location. OBJECTIVE: This study (EudraCT‐Number: 2005‐000025‐35) intended to evaluate the effect of subcutaneous immunoth...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Exp Allergy |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849700/ https://ncbi.nlm.nih.gov/pubmed/30570787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cea.13331 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|